???pagination.result.count???
???pagination.result.page???
1
The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease. , Camargo SM., J Pharmacol Exp Ther. October 1, 2014; 351 (1): 114-23.
Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. , Simmons-Willis TA., Biochem J. October 1, 2002; 367 (Pt 1): 239-46.
Human L-type amino acid transporter 1 ( LAT1): characterization of function and expression in tumor cell lines. , Yanagida O., Biochim Biophys Acta. October 1, 2001; 1514 (2): 291-302.
Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. , Kim JY ., Biochim Biophys Acta. June 6, 2001; 1512 (2): 335-44.
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-. , Bassi MT., Pflugers Arch. May 1, 2001; 442 (2): 286-96.
Cloning and characterization of a human brain Na(+)-independent transporter for small neutral amino acids that transports D-serine with high affinity. , Nakauchi J., Neurosci Lett. June 30, 2000; 287 (3): 231-5.
Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. , Fukasawa Y., J Biol Chem. March 31, 2000; 275 (13): 9690-8.
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. , Segawa H., J Biol Chem. July 9, 1999; 274 (28): 19745-51.
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. , Pineda M., J Biol Chem. July 9, 1999; 274 (28): 19738-44.